跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Norfine - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Norfine
Approved
STANDARD
Norfine
Kwality Pharmaceuticals Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
13ea7c001faad8a7
Company
Kwality Pharmaceuticals Ltd.
Type
Standard
Approval Details
Approval Id
13ea7c001faad8a7
Drug Approval Philippines Name
Norfine
Product Name
Norfine
Registration Number
DRP-16390
Brand Name
Norfine
Generic Name
Norepinephrine (as bitartrate)
Dosage Form
Solution for Injection (I.V.)
Dosage Strength
2 mg/2 mL
Manufacturer
Kwality Pharmaceuticals Ltd.
Importer
Pharma-Surrey International, Inc.
Distributor
Pharma-Surrey International, Inc.
Issuance Date
26 February 2025
Expiry Date
26 February 2030
Pharmacologic Category
Adrenergic and Dopaminergic Agent
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
13ea7c001faad8a7
Type
Standard
Back to Philippines FDA Approvals